Fever and Neutropenia

Fever and Neutropenia Guidelines

IDSA Fever and Neutropenia GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/91807

Contents of this Issue

Navigation

Page 12 of 15

Figure 1. Initial Management of Fever and Neutropenia Fever (≥ 38.3ºC) and Neutropenia (≤ 0.5 x 109 > Anticipated profound neutropenia (≤ 100 cells/mm3 Low Risk > Clinically stable AND > No medical comorbidities ) ≤ 7 days AND /L) > Anticipated profound neutropenia (≤ 100 cells/mm3 High Risk > Clinically unstable OR > Any medical comorbidies > Oral regimen if able to tolerate and absorb Outpatient Antibiotics > Availability of caregiver, telephone, transportation > Patient & physician decision Inpatient IV Antibiotics > Documented infection requiring IV antibiotics > Gastrointestinal intolerance > Patient & physician decision Oral ciprofloxacin + amoxicillin/ clavuanate and criteria met for outpatient management (see text) If responding patient remains stable prior to discharge for outpatient therapy clinic to ensure that empiric antibiotics are tolerated and Observe 4-24 h in Adjust antimicrobials based on specific clinical, radiograph and/or culture data, for example: > For cellulitis or pneumonia: vancomycin or linezolid > For pneumonia or Gram-negative bacteremia: add aminoglycoside and switch to carbapenem ) > 7 days OR Inpatient IV Antibiotics Empiric antibiotic monotherapy (any of the following): > Piperacillin/tazobactam OR > Carbapenem OR > Ceftazidime OR > Cefepime > For abdominal symptoms or suspected C. difficile infection: metronidazole 11

Articles in this issue

Archives of this issue

view archives of Fever and Neutropenia - Fever and Neutropenia Guidelines